BRAF GENE MUTATION
Clinical trials for BRAF GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF GENE MUTATION trials appear
Sign up with your email to follow new studies for BRAF GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Hard-to-Treat cancers: early trial recruits 554 patients
Disease control Recruiting nowThis study tests an experimental oral drug called S241656 (BDTX-4933) in people with advanced solid tumors that have certain genetic changes (KRAS, BRAF, or other RAS/MAPK mutations). The trial has two parts: first, finding a safe dose, then testing how well it works alone or wit…
Matched conditions: BRAF GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Last-Resort cancer drug made available for patients with specific gene mutations
Disease control AVAILABLEThis program provides the experimental drug ulixertinib to people with advanced solid tumors that have certain gene mutations (MAPK pathway). It is for patients who have not responded well to or have run out of standard treatments. The goal is to control the disease and possibly …
Matched conditions: BRAF GENE MUTATION
Sponsor: xCures • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Experimental cocktail aims to outsmart Drug-Resistant melanoma
Disease control Recruiting nowThis early-stage trial tests whether adding nilotinib to standard BRAF/MEK inhibitor therapy can help people with advanced melanoma whose cancer has stopped responding to treatment. About 30 participants will receive the drug combination to see if it is safe and tolerable. The go…
Matched conditions: BRAF GENE MUTATION
Phase: PHASE1 • Sponsor: Rina Plattner • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC